Inanga (Galaxias maculatus) are a culturally and economically important fish species in New Zealand and abroad. However, very little is known about their ability to deal with trace element contamination. As a scaleless fish with the ability to survive in relatively extreme environments, they may not fit toxicity models (such as the biotic ligand model; BLM) based on other fish species. The aim of this study was to determine how this fish responds to elevated trace elements in both the laboratory and field in order to determine the applicability of these toxicity models. In order to determine the impacts of stress on ion transport and subsequent metal toxicity, inanga were exposed to handling stress and measures of ion uptake were collected. Handling stress was shown to result in increased ventilation rates, resulting in stimulated sodium (Na+) efflux. A compensatory increase in Na+ influx was also measured as a result of this stress. Inanga largely recovered from this ionoregulatory stress within 2 hours, with full recovery after 24 hours. This was indicative of a rapid homeostatic response for maintaining ion balance. Enhanced Na+ uptake in response to this stress resulted in increased copper (Cu) uptake in Cu-contaminated water, suggesting stressed fish will accumulate more Cu (and likely other Na+ mimics) than an unstressed fish. These results suggest a heightened vulnerability of inanga to this type of contaminant as a result of exercise stress during migrations. A combination of field and laboratory studies was used in order to measure trace element accumulation in inanga. In situ field studies showed changes to aluminum (Al) and iron (Fe) body burdens when inanga were placed in streams of varying trace element concentrations along the West Coast of the South Island. However, other trace elements measured did not alter over the period of exposure (9-10 days). Biochemical biomarker analysis showed no changes in the activity of Na+/K+-ATPase (NKA), but a marker of lipid peroxidation (thiobarbituric acid reactive substances; TBARS) was elevated in one stream. Analysis suggested that stream pH was the major driver of this effect, whether directly or via changes to metal bioavailability. Subsequent laboratory exposures (96 h) of inanga to 1.2, 2.7, 10.8, and 44 µg L-1 dissolved Fe and 5.6, 23.3, 60.7, and 128.7 µg L-1 dissolved zinc (Zn) showed no difference in whole body trace element accumulation, ammonia excretion, ion influx (Ca2+ and Na+), and TBARS. There were significant differences in oxygen consumption (MO2) after Fe exposures, with increases in the 2.7 and 44 µg L-1 dissolved Fe exposures. Laboratory exposure results suggest inanga are relatively insensitive to short-term Fe and Zn exposures. Both in vivo (whole body partitioning) and in vitro (Ussing chamber) techniques were used to determine the influence of cutaneous ion transport on preventing trace element accumulation. Results suggest inanga use their skin as an additional site of calcium (Ca2+) and Na+ uptake. This is the first study to confirm these ion transport capabilities in inanga, and revealed that up to 48% of Na+ uptake may occur across the skin. Pharmacological inhibition of Ca2+ uptake was achieved by known Ca2+ channel blockers (verapamil and lanthanum). Furthermore Fe and Zn impaired cutaneous Ca2+ transport, indicating that ion transport pathways in the skin modulate in response to these metals.

The human mitochondrial DNA polymerase (Pol γ) catalyzes mitochondrial DNA synthesis, and thus is essential for the integrity of the organelle. Mutations of Pol γ have been implicated in more than 150 human diseases. Reduced Pol γ activity caused by inhibition of anti-HIV drugs targeted to HIV reverse transcriptase confers major drug toxicity. To illustrate the structural basis for mtDNA replication and facilitate rational design of antiviral drugs, I have determined the crystal structure of human Pol γ holoenzyme. The structure reveals heterotrimer architecture of Pol γ holoenzyme with a monomeric catalytic subunit Pol γA, and a dimeric processivity factor Pol γB. While the polymerase and exonuclease domains in Pol γA present high structural homology with the other members of the DNA Pol I family, the spacer between the two functional domains shows a unique fold, and constitutes the subunit interface. The structure suggests a novel mechanism for Pol γ’s high processivity of DNA replication. Furthermore, the structure reveals dissimilarity in the active sites between Pol γ and HIV RT, thereby indicating an exploitable space for design of less toxic anti-HIV drugs. Interestingly, the structure shows an asymmetric subunit interaction, that is, one monomer of dimeric Pol γB primarily participates in interactions with Pol γA. To understand the roles of each Pol γB monomer, I generated a monomeric human Pol γB variant by disrupting the dimeric interface of the subunit. Comparative studies of this variant and dimeric wild-type Pol γB reveal that each monomer in the dimeric Pol γB makes a distinct contribution to processivity: one monomer (proximal to Pol γA) increases DNA binding affinity whereas the other monomer (distal to Pol γA) enhances the rate of polymerization. The pol γ holoenzyme structure also gives a rationale to establish the genotypic-phenotypic relationship of many disease-implicated mutations, especially for those located outside of the conserved pol or exo domains. Using the structure as a guide, I characterized a substitution of Pol γA residue R232 that is located at the subunit interface but far from either active sites. Kinetic analyses reveal that the mutation has no effect on intrinsic Pol γA activity, but shows functional defects in the holoenzyme, including decreased polymerase activity and increased exonuclease activity, as well as reduced discrimination between mismatched and corrected base pair. Results provide a molecular rationale for the Pol γA-R232 substitution mediated mitochondrial diseases. / text

Poor aqueous solubility is one of the greatest barriers for new drug candidates to enter toxicology studies, let alone clinical trials. This thesis focuses on contributing to solving this problem, evaluating the oral toxicity of mesoporous silica particles, and enhancing the apparent solubility and bioavailability of active pharmaceutical ingredients in vitro and in vivo using mesoporous silica particles. Toxicological studies in rats showed that two types of mesoporous silica particles given by oral administration were well tolerated without showing clinical signs of toxicity. Solubility enhancement, including in vivo bioavailability and in vitro intracellular activity, has been evaluated for selected drug compounds. Mesoporous silica was shown to effectively increase drug solubility by stabilizing the amorphous state of APIs, such as itraconazole (anti-fungal), dasatinib (anti-cancer), atazanavir (anti-HIV) and PA-824 (anti-tuberculosis). Itraconazole was successfully loaded into a variety of porous silica materials showing a distinct improvement in the dissolution properties in comparison to non-porous silica materials (and the free drug). Microporosity in SBA-15 particles has advantages in stabilizing the supersaturation state of dasatinib. Small pore sizes show better confinement of atazanavir, contributing to a higher dissolution of the drug compound. In the in vivo animal studies, NFM-1 loaded with atazanavir shows a four-fold increase in bioavailability compared to free crystalline atazanavir. PA-824 has a higher dissolution rate and solubility after loading into AMS-6 mesoporous particles. The loaded particles show similar antibacterial activity as the free PA-824. This thesis aims at highlighting some of the important factors enabling the selection of adequate mesoporous structures to enhance the pharmacokinetic profile of poorly water-soluble compounds, and preparing the scientific framework for uncovering the effects of drug confinement within mesopores of varying structural properties. / <p>At the time of the doctoral defense, the following papers were unpublished and had a status as follows: Paper 2: Submitted. Paper 3: Submitted. Paper 5: Submitted.</p>

Nanotechnology is an increasing market. Engineered nanoparticles (NPs), materials with at least one dimension between 1 and 100 nm, are produced on a large scale. NPs are vastly used in industrial processes and consumer products and they are most likely discharged into wastewater treatment plants after being used. Activated Sludge is one of the most applied biological wastewater treatment processes for the degradation of organic matter in sewage. Activated sludge produces an excess of sludge that is commonly treated and stabilized by anaerobic digestion. Recent studies have found that NPs accumulate in the activated sludge; thus, there is a potential for the concentrations of NPs to magnify as concentrated waste sludge is fed into the anaerobic digestion process. For this reason, it is important to study the possible toxic effects of NPs on the microorganisms involved in the anaerobic digestion process and the approaches to overcome toxicity if necessary. The present work evaluates the toxic effect of NPs on anaerobic wastewater treatment processes and also presents approaches for toxicity attenuation. The first objective of this dissertation (Chapter III) was to evaluate the toxicity of high concentrations (1, 500 mg L⁻¹) of Ag⁰, Al₂O₃, CeO₂, Cu⁰, CuO, Fe⁰, Fe₂O₃, Mn₂O₃, SiO₂, TiO₂, and ZnO NPs to acetoclastic and hydrogenotrophic methanogens and the effect of a dispersant on the NPs toxicity to methanogens. The findings indicated that only Cu⁰ and ZnO NPs caused severe toxicity to hydrogenotrophic methanogens and Cu⁰, CuO, and ZnO NPs to acetoclastic methanogens. The dispersant did not impact the NPs toxicity. The concentrations of Cu⁰ and ZnO causing 50% of inhibition (IC₅₀) to hydrogenotrophic methanogens were 68 and 250 mg L⁻¹, respectively. Whereas the IC₅₀ values for acetoclastic methanogens were 62, 68, and 179 for Cu⁰, ZnO, and CuO-Cu NPs respectively. These findings indicate that acetoclastic methanogens are more sensitive to NP toxicity compared to hydrogenotrophic methanogens and that Cu⁰ and ZnO NPs are highly toxic to both. Additionally, it was observed that the toxicity of any given metal was highly correlated with its final dissolved concentration in the assay irrespective of whether it was initially added as a NP or chloride salt, indicating that corrosion and dissolution of metals from NPs may have been responsible for the toxicity. The second objective of this dissertation (Chapter IV) was to evaluate the Cu⁰ NP toxicity to anaerobic microorganisms of wastewater treatment processes. Cu⁰ is known to be toxic to methanogens; nonetheless, little is known about its toxic effects on microorganisms of upper trophic levels of anaerobic digestion or other anaerobic process used for nitrogen removal. This specific objective evaluated Cu⁰ NP toxicity to glucose fermentation, syntrophic propionic oxidation, methanogenesis, denitrification and anaerobic ammonium oxidation (anammox). Chapter IV showed that anammox and glucose fermentation were the least and most inhibited processes with inhibition constants (K(i)) values of 0.324 and 0.004 mM of added Cu⁰ NPs, respectively. The Ki values obtained from the residual soluble concentration of the parallel experiments using CuCl₂ indicated that Cu⁰ NP toxicity is most likely caused by the release of soluble ions for each one of the microorganisms tested. The results taken as a whole demonstrate that Cu⁰ NPs are toxic to a variety of anaerobic microorganisms of wastewater treatment processes. The third objective of this document (Chapter V) was to study the role of biogenic sulfide in attenuating Cu⁰ and ZnO NP toxicity to acetoclastic methanogens. Previous literature results and research presented in this dissertation indicated that the release of soluble ions from Cu and ZnO NPs cause toxicity to methanogens. In the past, the application of sulfide to precipitate heavy metals as inert non-soluble sulfides was used to attenuate the toxicity of Cu and Zn salts. Building on this principle, Chapter V evaluated the toxicity of Cu⁰ and ZnO NPs in sulfate-containing (0.4 mM) and sulfate-free conditions. The results show that Cu⁰ and ZnO were 7 and 14x less toxic in sulfate-containing than in sulfate-free assays as indicated by the differences in K(i) values. The K(i) values obtained based on the residual metal concentration of the sulfate-free and sulfate-containing assays were very similar, indicating that the toxicity is well correlated with the release of soluble ions. Overall, this study demonstrated that biogenic sulfide is an effective attenuator of Cu⁰ and ZnO NP toxicity to acetoclastic methanogens. Finally, the last objective (Chapter VI) of this dissertation was to evaluate the effect of iron sulfide (FeS) on the attenuation of Cu⁰ and ZnO toxicity to acetoclastic methanogens. FeS is formed by the reaction of iron(II) and sulfide. This reaction is common in anaerobic sediments where the reduction of iron(III) to iron(II) and sulfate to sulfide occurs. FeS plays a key role controlling the soluble concentrations of heavy metals and thus their toxic effects in aquatic sediments. This study evaluated the application of FeS as an approach to attenuate Cu⁰ and ZnO NP toxicity and their salt analogs to acetoclastic methanogens. Two particle sizes, coarse FeS (FeS-c, 500-1200 µm) and fine FeS (FeS-f, 25-75 µm) were synthesized and used in this study. The results showed 2.5x less FeS-f than FeS-c was required to recover the methanogenic activity to the same extent from the exposure to highly inhibitory concentrations of CuCl₂ and ZnCl₂ (0.2 mM). The results also showed that a molar ratio of FeS-f/Cu⁰, FeS-f/ZnO, FeS-f/Zn Cl₂, and FeS-f/CuCl₂ of 3, 3, 6, and 12 respectively, was necessary to provide a high recovery of methanogenic activity (>75%). The excess of FeS needed to overcome the toxicity indicates that not all the sulfide in FeS was readily available to attenuate the toxicity. Overall, Chapter VI demonstrated that FeS is an effective attenuator of the toxicity of Cu⁰ NP and ZnO NPs and their salt analogs to methanogens, albeit molar excesses of FeS were required.

Studies in this dissertation were conducted to explore the roles of organic cation transporters (OCTs) in the disposition of N-butylpyridinium Chloride (NBuPy-Cl) and structurally related ILs. Following a single i.v. dose to rats, the blood concentration of NBuPy-Cl and 1-butyl-1-methylpyrrolidinium chloride (BmPy-Cl) decreased in a biphasic manner with a clearance of 3.3 and 7 ml/min, respectively. More than 84% of dosed compounds were excreted in the urine. Depending on the vehicle, the dermal absorption of BmPy-Cl and NBuPy-Cl (5 mg/kg, 125 μg/cm²) was 10-35% at 96 h. Following a single oral (50 mg/kg) administration to rats, the maximum blood concentrations of both ILs were reached in less than 90 min in rats. Most of the orally dosed NBuPy-Cl (62-68 %) was excreted in the urine in 72 h. However, more of the dosed BmPy-Cl was eliminated in the feces Its oral bioavailability was only 47%. The elimination differences between BmPy-Cl and NBuPy-Cl were not altered by the size (0.5, 5, or 50 mg/kg) or frequency (1 or 5 administrations) of oral doses. In all urine and blood samples, only parent compounds were detected. Co-administration of NBuPy-Cl and inulin intravenously to rats revealed that the clearance of NBuPy-Cl exceeded the rat glomerular filtration rate, suggesting a renal secretion processing. The in vitro transport studies demonstrated that NBuPy-Cl, BmPy-Cl and 1-butyl-3-methylimidazolium chloride are substrates (Kt, 9~277 μM), as well as inhibitors (IC₅₀: 0.2~7.5 μM), of rOCT1/2 and hOCT2. Their inhibitory effects increased dramatically with increasing the alkyl chain length. The IC₅₀ values were 0.1, 3.8, 14 and 671 μM (hexyl-, butyl-, ethyl-pyridinium and pyridinium chloride) for rOCT2 mediated metformin transport. Similar structurally related inhibitory kinetics were observed for rOCT1 and hOCT2. In vivo co-administration of NBuPy-Cl prolonged the plasma half-life and reduced renal clearance of the diabetic drug, metformin. In summary, BmPy-Cl and NBuPy-Cl are partially absorbed from gastrointestinal tract. The present in blood is eliminated rapidly in the urine as parent, by renal filtration and OCT-mediated secretion. ILs also compete with other substrates of OCTs and have the potential to alter their pharmacokinetic profiles.

Since the discovery of mycotoxins in food, the thrust of biochemical and toxicological research has been carried out on animals which has proven to be uncoordinated and not easily extrapolated to humans. Over the last decade, there have been increasing pressures to review and reduce the use of animals in experimental toxicological studies. Consequently in this study aflatoxin B1 (AFB1), zearalenone (Zea) and their epoxide derivatives have been evaluated using in vitro assays. The HepG2, A549 and Hela cell lines were used for assessing the cytotoxicity, effects on cellular metabolism and sites of action of AFB1, Zea and their derivatives. The cytotoxicity of these mycotoxins was evaluated using the methylthiazol tetrazolium (MTT) reduction assay. Cells, treated with mycotoxins were prepared for transmission electron mlcroscopy (TEM), immunocytochemistry (ICC), scanning electron microscopy (SEM), confocal and light microscopy. From the cytotoxicity assay it was found that the epoxide derivatives were more toxic than the parent toxin when exposed to HepG2 cells with no significant differences in toxicity levels in A549 and Hela treated cells. Both epoxide derivatives displayed a regression of hepatoma cell proliferation at high doses (25ug/ml) while lower concentrations (<12.5ug/ml) enhanced cell growth. Microscopy analyses showed distinct cellular alterations. When exposed to AFB1 (12.5ug/ml) hepatoma cells showed prominent ultrastructural alterations such as areas of cytoplasmic lysis and increased numbers of secondary lysosomes while cells exposed to Zea (l2.5ug/ml) displayed numerous ovoid mitochondria and proliferation of rough endoplasmic reticulum which is indicative of enhanced protein synthesis. The presence of label in toxin treated cells is suggestive of the effects of these mycotoxins. Such cellular changes may lead to altered metabolism and cell function. / Thesis (M.Med.)-University of Natal, Durban, 1996.

Aflatoxin B1 (AFB1) and Fumonisin B1 (FB1), potentially cytotoxic and carcinogenic mycotoxins are common contaminants of agricultural commodities in South Africa and thus could be detrimental to the human immune system. Many of the cytotoxic effects of AFB1 require its bioactivation to an epoxide, which will bind covalently to macromolecules to form protein and DNA adducts. Fumonisin B1 is a competitive inhibitor of sphingosine and sphinganine N aceyltransferase, which are key components in the pathways for sphingolipid biosynthesis. Accumulation of free sphingoid bases, which are both cytotoxic and mitogenic, could provide a plausible explanation for the toxicity and carcinogenicity of FB1. The cytotoxic effects of AFB1 and FB1 on normal human lymphocytes, individually and in combination were assessed using the methylthiazol tetrazolium (MTT) bioassay. Two different methods of treatment were used, the treatment of isolated normal human lymphocytes for 12, 24, 48, 72 and 96 hours and whole blood treated for 12 hours. Flow cytometry and fluorescent microscopy were used to determine whether AFB1 and FB1 (5uM and 50uM), individually or in combination, were capable of inducing apoptosis, necrosis or nuclear fragmentation in isolated lymphocytes and whole blood treated for 12 hours. DNA damage was evaluated using the comet assay. The results showed that AFB1routinely induced higher levels of cytotoxicity in isolated lymphocytes than FB1. In the combination treatment, the mitogenic properties of FB1 appeared to partially counteract the cytotoxic effect exerted by AFB1. When whole blood was treated with the same concentration and ratio of toxin, FB1 was shown to be more cytotoxic than AFB1. The combination treatment of whole blood was shown to be cytotoxic in a dose dependent manner. The toxins appeared to exert a greater cytotoxic effect, when treated in combination than individually at higher concentrations. Aflatoxin B1 induced increased levels of apoptosis and necrosis in isolated lymphocytes while treatment with the FB1 resulted in increased levels of apoptosis at both concentrations. Treatment with the combination also resulted in increased levels of apoptosis. The levels of apoptosis were reduced in whole blood lymphocytes when compared to isolated lymphocytes. However, treatment with AFB1 and FB1 resulted in increased levels of apoptosis. Both AFB1 and FB1 are capable of inducing nuclear fragmentation. Treatment with FB1 (5uM and 50uM) resulted in greater degree of fragmentation than AFB1. The most nuclear fragmentation was induced by the 5uM combination treatment. The 50uM combination treatment of isolated lymphocytes induced the most DNA damage. As both toxins are common contaminants and have been known to coexist, this could be a potential area of concern for public health. / Thesis (M.Med.)-University of KwaZulu-Natal, 2004.

Exposure to methyl mercury (MeHg) is a global concern. Increased chronic exposure to MeHg among fish and marine mammal consuming populations will increase the risk of prenatal exposure and as a result, the risk of infant brain damage and neurotoxcity. It is therefore important to understand the role of environmental factors, such as nutrition, in determining susceptibility to MeHg toxicity. Three nutrients (selenium (Se), vitamin C and vitamin E) were selected for examination of their interactions with the mechanisms of McHg cytotoxicity in vitro. Two hybrid neural cell lines (M03.13 and NSC-34) were evaluated for their usefulness in the study of MeHg cytotoxicity. Sixteen toxic endpoints were selected for investigation of growth, viability, structure and biochemistry. Both cell lines responded to MeHg exposure in a dose dependent manner for the majority of endpoints suggesting that both MO3.13 and NSC-34 cells undergo structural and biochemical changes during exposure to McHg, but that MO3.13 cells are more sensitive to DNA, mitochondria) membrane damage and glutathione (GSH) depletion and that NSC-34 cells are more sensitive to protein damage and apoptosis. Se exposure lessened the MeHg-induced decrease in DNA and GSH concentrations in both cell lines. In NSC-34 cells, Se also increased F-actin concentrations and prevented an increase in caspase-3 activity. Se may alter the mechanism of cell death by preventing McHg disruption of DNA replication thus maintaining the production and function of peptides (GSH) and protein (polymerized actin) that aid in MeHg detoxification and neural function. In NSC-34 cells, vitamin C prevented the induction of caspase-3 activity and lessened DNA damage and GSH depletion. Vitamin E lessened GSH depletion and lessened G-actin depletion. Both vitamin C and E improved GSH status, but vitamin C also delayed McHg damage of DNA and prevented early signs of apoptosis suggesting these two vitamins interfere with MeHg metabolism by diffe

Dietary cadmium (Cd) can contribute significantly to chronic bioaccumulation and toxicity in aquatic organisms. This contribution needs to be quantified so that the relative importance of waterborne and dietary cadmium exposure pathways can be incorporated into protective water quality guidelines and ecological risk assessments. In this research, the contribution of dietary Cd from a natural periphyton diet to chronic (28 d) bioaccumulation and toxicity in the freshwater amphipod Hyalella azteca was quantified using a mechanistically-based saturation bioaccumulation model. Factors that influence dietary Cd bioavailability such as food type, food form, dietary Cd speciation and concentration were investigated. Assimilation efficiency, ingestion rate and the excretion rate constant of dietary Cd were determined for each of these factors. Food nutrition was also considered. Lastly, model predictions of Cd bioaccumulation and toxicity were compared to measurements of tissue concentration and survival when H. azteca were exposed to metal contaminated water and periphyton collected from lakes in the metal mining region of Rouyn-Noranda, Quebec, Canada. In 28 d laboratory experiments where H. azteca bioaccumulated Cd from water and food, dietary Cd was estimated to contribute markedly (21 – 94 %) to bioaccumulated Cd in H. azteca. Effects on chronic survival were best predicted from body concentration rather than water or food exposure concentration. Assimilation efficiency of dietary Cd differed with food type likely as a result of Cd speciation, but did not differ with Cd concentration or food form. Ingestion rate differed with food form while excretion rate constants were unaffected by dietary Cd bioavailability. Predictions of chronic Cd bioaccumulation in H. azteca exposed to field contaminated samples were robust, however the model did not account for effects of water chemistry on Cd bioaccumulation and is thus constrained in its application. Predictions of chronic survival were over-estimated likely due to the additional toxicity caused by the low nutritional quality of the field contaminated periphyton. This research demonstrated that both waterborne and dietary Cd need to be considered in models that assess chronic risk of exposure and effects to H. azteca.

Alkyl-polycyclic aromatic hydrocarbons (alkyl-PAHs) constitute more than 90% of the total PAHs in crude oil and are the main constituents toxic to fish. Little characterization of alkyl-PAHs has been reported and is needed to predict the effects of crude oil following spills. The objectives of this thesis were: (1) to evaluate the toxicity of alkyl-phenanthrenes and alkyl-anthracenes to the early life-stages of medaka (Oryzias latipes) using the partition controlled delivery of toxicants (PCD); (2) to investigate the effect of light on alkyl-anthracene toxicity; (3) to further characterize the PCD method; (4) to better understand alkyl-PAH mechanisms of toxicity; and (5) to identify the major phase I and phase II alkyl-PAH metabolites in rainbow trout (Oncorhynchus mykiss) and in medaka by both in vitro and in vivo methods. It was determined that the toxicity of both series of alkyl-PAHs increased with the number of carbon substituents on the rings. Some alkyl-PAHs had EC50 values lower than the value from conventional semi-static exposure methods. These values were below the water solubility limit, consistent with the ability of PCD to correct for values from nominal concentrations above solubility. PCD provided stable concentrations for up to 17 days but could not always compensate for losses of alkyl-anthracenes by photodegradation. Both series of alkyl-PAHs were toxic through different mechanisms that resulted from their physical and chemical properties. Alkyl-phenanthrenes such as 7-isopropyl-1-methylphenanthrene (retene) were more toxic to medaka embryos than phenanthrene. The appearance of blue sac disease suggested toxicity enhancement through the aryl hydrocarbon receptor pathway. Alkyl-anthracenes were toxic by narcosis in the absence of light and by phototoxicity in the presence of light. The photoproducts of alkyl-anthracenes were not toxic to fish. The in vitro phase I metabolism by rainbow trout CYP1a enzymes and in vivo phase II metabolism in rainbow trout produced alkyl-anthracenes metabolites substituted mainly on the ring system. The phase II in vivo metabolites of alkyl-phenanthrenes in medaka larvae were substituted mainly on their alkyl chains. For all alkyl-PAHs, a predominance of glucuronide conjugates was identified in the phase II metabolites. This characterization of the toxicity of alkyl-PAHs may contribute to predicting the toxicity of crude oil based on its composition. / Thesis (Ph.D, Chemistry) -- Queen's University, 2008-08-29 14:18:10.308